Samir N Khleif

7PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 12, 2026
PARP inhibition generates enhanced CD8+ central memory T cells by transcriptional and metabolic reprogramming.

Wael Traboulsi, Pankaj Gaur, Subhadip Kundu

|Oct 16, 2025
Cancer vaccines as enablers of immunotherapy.

Samir N Khleif, Seema Gupta

|Mar 15, 2022
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status.

Rahul Nandre, Vivek Verma, Pankaj Gaur

|Jan 20, 2022
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.

Altaf Mohammed, Roderick H Dashwood, Sally Dickinson

|Nov 24, 2020
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects.

Vivek Verma, Nazli Jafarzadeh, Shannon Boi

|Sep 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.

Vivek Verma, Rajeev K Shrimali, Shamim Ahmad

Pageof 2

Frequent Collaborators

4 joint publications

Seema Gupta

3 joint publications

Vivek Verma

2 joint publications

Keith T Flaherty

2 joint publications

Jennifer A Wargo